chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported red, swollen, and warm to the touch right bicep approximately 2 hours after vaccination. Also had chills and pain radiating to chest. Also reported when he blinked his eyes objects were vibrating but that went away. He reported this to me the following morning around 9:45am. Symptoms improved slightly. I advised that he may need to see primary physician to get checked out. He said he'd wait and see if cleared up and would go to his doctor if not better.
PATIENT IS A HEALTHCARE WORKER STOPPED BY PHARMACY DURING OUR OFF SITE FLU CLINIC 9/24/20.  FEW DAYS LATER HAD AN EARACHE.
eyes hurting; his vision was not focused to well; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Batch/lot number: EL9269 and expiry date was not reported) via an unspecified route of administration, in the left arm, on 04Feb2021 at 10:30 as a single dose for covid-19 immunisation. Patient's medical history, relevant family medical history and concomitant medications were not reported. No history of all previous immunization with the Pfizer vaccine considered as suspect and no additional vaccines administered on same date of the suspect. Patient received prior vaccinations within 4 weeks included flu shot about 3 weeks ago. On 05Feb2021, patient experienced eyes hurting and with vision not being focused well. No relevant tests were done. The outcome of events was resolving.  Follow-up attempts are completed. No further information is expected.
"flu-like" symptoms; 10.6 temperature; all sorts of aches; chills; headaches; joint aches; This is a spontaneous report from a contactable consumer (patient). A 76-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration was not reported), via an unspecified route of administration on 02Feb2021 as second dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Previously, patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration was not reported), via an unspecified route of administration on unspecified date as first dose, single for covid-19 immunisation. The patient received the second dose of the COVID-19 vaccine 02Feb2021 (yesterday) afternoon. The patient was experiencing "flu-like" symptoms on 03Feb2021 (today) and listed the following: "chills, 10.6 temperature, all sorts of aches, headaches, and joint aches". The patient specified she "woke up during the night with a very bad headache" and she "took two TYLENOL" as therapeutic measures. The patient underwent lab tests and procedures which included Body temperature as 10.6 on 03Feb2021. The outcome for all the events was unknown.  Information on the Lot/Batch Number has been requested.  Follow-up attempts are completed. No further information is expected.
Patient did receive 2nd dose of Moderna COVID-19 vaccine on 2-20-2021. He claims that every since he had received the COVID vaccine, he has had ringing in his ears beginning in March. He has seen an audiologist and this prescriber stated that their office has been seeing in increase in complaints of ringing in the ears since more individuals have receieved the COVID vaccine. The patient requested that we report the adverse event.
PMH:  mitral valve replacement, HTN, depression; admitted to hosp with HRF secondary to COVID pneumonia; cough, fever, aches, diarrhea and SOB; given antiviral steroids and bronchodilators; intubated; experienced A Fib, anemia, given multiple transfusions; underwent tracheostomy and percutaneous endoscopic gastric placement; mental status declined; MRI showed multifocal cerebral infarction; family chose to withdraw care and pt died in the hosp
I had stayed with her Wed night and she seemed fine. Thurs morning I left about 2 in the afternoon. The next morning I found out she didn't feel like eating that night and had been vomiting and the caregiver that came told me that also she was a little unresponsive and didn't feel like eating anything. Caregiver thought to call the EMS and they evaluated her, at that time (9am) she was responsive and doing ok  and advised not to take her to ER due to Covid situation. We decided not to take her. About 10 caregiver called back and she had fainted and couldn't get up by herself. And she called EMS again and they came out and she was sitting up at that time and she was responsive again. They again advised that with the 2hr wait in the ambulance and advised that if it was their mother they wouldn't take her. Since she was responsive she said she didn't want to go to the ER. Another night caregiver came to stay with my Mom. The caregiver called and had called EMS and they were taking her to the ER because she became unresponsive again and was seen by Dr. and she was admitted to the hospital. Bunch of tests were run and she was there from Sept 10th until she passed away Sept 22. While there she couldn't eat anything and she had a hernia where her stomach was coming up to her esophagus. And after a endoscopy she took a turn for the worse. They couldn't draw blood because her veins started collapsing. they weren't' able to get her any medications or nutrients through her veins because I guess her body was shutting down. On the 20th she was admitted into hospice.
COVID 19 Treatment; COVID 19 Treatment; vaccine brand=Pfizer / BioNTech,vaccine dose number=2; vaccine brand other=Moderna,vaccine dose number=3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Nov2022 as dose 5 (booster), single (Lot number: FP7139) at the age of 58 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: en6205), in right arm and on 24Mar2021 as dose 2, single (Lot number: ER8732), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 08Nov2021 as dose 3 (booster), single (Lot number: 065F4A), in right arm and on 19May2022 as dose 4 (booster), single (Lot number: 038A22A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Occasional mild asthma" (unspecified if ongoing), notes: Occasional mild asthma; "known allergies: Mild peanut" (unspecified if ongoing), notes: known allergies: Mild peanut. Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 08Nov2021, outcome "unknown", described as "vaccine brand=Pfizer / BioNTech,vaccine dose number=2; vaccine brand other=Moderna,vaccine dose number=3"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient received Vitamin C and Solgar medication in two weeks,
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 15-MAR-2014, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry date, route, dose, strength and indication not reported). The pharmacist reported that the unspecified patient experienced blisters on lower lip, itching and tingling after receiving ZOSTAVAX. The patient was advised by pharmacist to take CLARITIN and patient applied BENADRYL topically to blisters. The patient informed pharmacist that she experienced a huge redness and rash around injection site on 18-MAR-2014. The pharmacist asked if patient should see her unspecified physician. The outcome of the events was unknown. Additional information has been requested.
Head drop with shoulder shrug with full cognition several times a day and it escalated to several times an hour.  Symptoms worsened significantly by 1 month post vaccine and resolved completely 2 months post vaccine.  No vomiting, no diarrhea, no seizures, no fever, no illnesses after vaccine.  No loss of developmental milestones.  Growth NL.
Vaccine was administered, within 5 seconds patient passed out for less then 15 seconds. Father and patient admitted past history of fear of needles when given flu vaccine and blood drawn. Patient had not eaten or consumed fluids morning of vaccination
Loud tinnitus creating and achey head. Feels like I just left a loud concert all the time.
Probable focal seizure with left arm extended straight and right arm flexed, lasted , 1 minute then was sleeping?
NUMBNESS, TINGLING AND WAXY WHITE FINGERS IN BILATERAL THUMBS, FOREFINGERS, AND MIDDLE FINGERS. PRESENTED SIMILAR TO RAYNAUD'S SYNDROME. ONCE HANDS WERE WARMED UNDER WARM WATER, SYMPTOMS SUBSIDED.
Had MMR on 24 June 2002. Called 26 June. Seen July 1. Had large whelps, pruritic over trunk and extremities. No fever. Does have low appetite.
*Sore arm, bruise with in 1 day of injections.  *Rash about 6 days after dose at the injection site. Was also itching and hot to the touch . Lasted for about 10 days
Patient is a 27 year old male with history of allergic rhinitis.  He moved to the area in April 2021 and had some initial problems with pollen allergies, but had improved and doing well with Singulair.  He had COVID19 in November 2020, recovered fairly quickly and did not have much in the way of breathing difficulties.  Last month he received both doses of Moderna COVID19 vaccination, second dose administered on 5/25/2021.  After his second dose, he has become progressively more ill.  He did have a fever up to 105F for 24 hours afterwards, but this resolved. He has gone to several urgent cares due to progressively worsening SOB, cough, and malaise.  Coworkers have commented to him that he is just not himself and is slow to get around.  He has gotten to the point he cannot take the trash out without having to stop to catch his breath.  He has been treated with a variety of regimens, including amoxicillin, doxycycline, inhalers, prednisone, and IM steroid shots.  He does get brief mild relief with albuterol inhaler.
Case number PHEH2013US015634 is an initial spontaneous report received from a physician on 22 Jul 2013. This report refers to 2-months old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MenCYW-135 of MENVEO (batch number: X11071) intramuscularly in error instead of PREVENAR (other manufacturer, batch number: not reported) on 22 Jul 2013. No adverse event was reported following the inadvertent administration.
About 48 hours after booster shot, I developed swollen lymph nodes and tenderness in left axilla
Rash at the injection site and neck  Benadryl PO 25 mg - patient feel better c/o tingling - advise to stay for OBS and further evaluation - patient declined and wants to go home for child school Elevated BP - BP -  patient wants to follow up with her doctor
INITIAL:  MYALGIA, ARTHRALGIA, WEAKNESS; POST SYMPTOM DX: POLYMYALGIA RHEUMATICA, MGUS, RHEUMATOLOGY: TRIGGERED BY FLU SHOT?
Headache, Myalgia, Fever, CoughWheeze, fatigue, chills Narrative:
pt recv vax & was lightheaded, dizzy, pale, skin cool & dry;head lowered to knees & color improved;pt positioned on floor w/legs elevated;became dizzy & started to collapse;was unconscious briefly 5-10sec leg elevated R20, P64,BP 100/60, h/
Information has been received from a pharmacist referring to an unspecified number of patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On unspecified dates, the patients were administered improperly stored doses of PEDAXHIB (lot #, dose and route unknown). The vaccines were exposed at 63 Fahrenheit for 156 hours. There was no previous temperature excursion. No adverse effect was reported. This is one of two reports received from the same reporter. Additional information has been requested.
Difficulty breathing, upper airway constriction, SaO2 was 72% on room air.  Red itchy ears (within 15minutes of injection) which progressed to full body red rash with hives to cheeks, arms, and legs (within 30 minutes of injection).  Anxiety. Treatment was received extremely quickly before cardiovascular system was effected.  I took him straight from clinic to ER less than 1 mile away.  He received an oral dose of benadryl and a xopenex neb treatment at the clinic (pt own home meds - he has the same reaction to milk and I keep these things on me at all times - would have administered epi-pen if hadn't been so close to ER - presented at first like asthma attack from upsetting situation of getting 3 immunizations).  At ER received O2, SQ epinephrine, albuterol neb tx, IV solumedrol and additional benadryl IV.  We were sent home with oral prednisolone and antihistamines.
Information has been received from a Registered Nurse referring to a 2 year old female patient. On 23-MAR-2016 at 10:52, the patient was intramuscularly vaccinated with an improperly stored (Temperature: 32F - Time frame: 5 minutes) dose of VAQTA (second dose, lot # K012457, dose was unknown) in right deltoid. No adverse effect was reported. This is one of several reports received form the same reporter. Additional information is not expected as all correspondence was received.
Moderate soreness in left deltoid muscle, joint aches, malaise, fever at 100.4 degrees, cough.
This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 54-year-old male patient received BNT162b2 (BNT162B2), on 01Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 53 years, in right arm for Covid-19 immunisation; CoviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "Overweight" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19/Worse COVID symptoms: Nasal congestion runny eyes cough slight fever fluctuating pulse OX, some chest pain". Therapeutic measures were taken as a result of drug ineffective, Covid-19, Paxlovid. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
1 of 3 pts w/in a 1wk period who exp an inj site rxn consisting of redness & swelling following vax
Qudracel instead of Pentacel was administered to a 11 week old male patient in error/no AE; Qudracel instead of Pentacel was administered to a 11 week old male patient in error/no AE; Qudracel instead of Pentacel was administered to a 11 week old male patient in error/no AE; Initial information received on 15-Jan-2020 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 11-weeks-old male patient who by mistake received 0.5 ml single dose of vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot C5532AA via unknown route in the left thigh) instead of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] on 15-Jan-2020.  The patient medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis B Vaccine (Hepatitis B Vaccine) (dosing details not reported) on an unknown date.  It was an actual medication error case due to wrong vaccine administered, inappropriate age at vaccine administration because QUADRACEL is recommended in person from age 04 years; vaccine administered at inappropriate site because QUADRACEL should be administered in deltoid muscle of the upper arm.  It was unknown whether adverse reaction was experienced or not.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
The patient presented to Hospital on 02/20/2022 in cardiac arrest.  Pre-arrival treatment included CPR, Oxygen, intubation, defibrillated, and epi.  ROSC was achieved prior to arrival.  The patient's hospital course was complicated by aspiration PNA and Covid.  The patient worsened throughout the ICU course.  Palliative care was consulted on 02/23/2022.  The patient was transitioned to comfort care on 02/26/2022.  The patient expired on 02/27/2022.
Medication error-infant was inadvertently given an adult dose of Zostavax instead of age appropriate dose of ProQuad.
This vaccine was administered on 12/23/2020.  On 12/30/2020 I experienced intermittent headaches (waking me during the night), very heavy pressure between the breasts, fatigue and extreme redness, swelling, itching at injection site. I went to emergency clinic on 1/1/2021.  The performed blood work, EKG, Chest X -Ray, took vital signs and all were normal.  All symptoms have disappeared as of today, 1/2/2021, except the redness and extreme tenderness at injection site.
Patient came to us 10/13/14 (14 days after shot) - said shoulder soreness started day after shot then progressed to neck and head pain and cannot move arm all the way up w/ out pain - I referred her to her doctor but she did not see her (only called in a muscle relaxer).
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown demographics. No concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with doses of improperly stored M-M-R II injection (lot # K021151, expiry date: 02-NOV-2016, strength, dose, site and route of administration were unspecified). No concomitant medications were reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Narrative: COVID infections following completion of COVID vaccine series 12/30/20 COVID vaccine dose #1 01/20/21 COVID vaccine dose #2 08/01/21 Pt presents for preop COVID test and reports no symptoms; COVID POSITIVE 08/02/21 Pt remains asymptomatic 08/18/21 Pt remains asymptomatic
Arm was really hurting; Really tired; She received the vaccine and she saw that the vaccine was expired; This spontaneous case was received on 11-Oct-2022 from other non-healtcare professional (consumer) via Med Communications (reference number: SEQW22-04347) and concerned a 21-year-old, female patient.  The patient's concurrent condition included lupus. The patient  was not taking any concomitant medications.  On 10-Oct-2022, the patient was vaccinated with expired Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5ml, route of administration: intramuscular and anatomical location: not reported) for influenza prophylaxis (explicitly coded as 'Expired vaccine used'). The batch number was not reported.  On the same date, after receiving Flucelvax Quadrivalent, the patient started to be really tired and her arm was realy hurting. She took ibuprofen as a treatment measures.  The outcome of the events was not reported.  This case was assessed as non-serious.  Company comment: A 21-year-old, female patient was vaccinated with expired Flucelvax Quadrivalent. On the same date, after vaccination, the patient started to developed fatigue and pain in arm. Causality is assessed as possibly related for the events of fatigue and pain in arm. Expired product administered is assessed as unrelated per company's conventions.; Sender's Comments: A 21-year-old, female patient was vaccinated with expired Flucelvax Quadrivalent. On the same date, after vaccination, the patient started to developed fatigue and pain in arm. Causality is assessed as possibly related for the events of fatigue and pain in arm. Expired product administered is assessed as unrelated per company's conventions.
1.on 1/10 started noticing a rash on her lower legs around her ankles. Kind of just little red dots. 2. The rash kept spreading and getting worse with bigger red blotches all up and down her legs but most heavily concentrated on her lower legs and feet. So, on 1/15 we went to the doctor about the rash, the coughing and an acheness. He didn't know what it was and did some blood work that we wouldn't find out about until Monday (this was Friday). 3. On the evening of 1/17, she had swollen up so bad on her lower legs and ankles that you couldn't see any of her ankle bones, etc. Also was saying that she couldn't hardly swallow so I was concerned that throat was swelling like the legs. So, I took her to the emergency room. They did blood work but said nothing showed up.  They started tossing out possible things like lupus and auto-immune disease. I don't think I told the doctors there about her just having had the 3rd gardisell shot. They gave her 60 mg a day of prednisone for 4 days. 4. As of 1/30, she is in severe pain on her lower legs, fatigued, stomach hurts, very nauseous which could be from meds.  We have been in repeated contact with the doctor and after several changes in doses of prednisone, she is currently doing 40 mg a day, Lortab as needed for pain and a diuretic. She couldn't go to school Thursday. The days prior she could go but by the end of the day her legs were so swollen and hurt and she could hardly move or use her left one which is the worse. She has now been on the couch or in bed for 3 days straight.
sore arm in the arm of administration that subsided; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm in the arm of administration that subsided) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Kidney disorder, Aortic aneurysm and Heart disease, unspecified. Concurrent medical conditions included COPD. Concomitant products included LEVOTHYROXINE, LEVOTHYROXINE SODIUM (SYNTHROID) and ATORVASTATIN for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm in the arm of administration that subsided). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (sore arm in the arm of administration that subsided) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
spine inflammation. started as if was only a back right shoulder spasm, but kept gradually increasing pain intensity thru next days. realized the pain really comes from the one location in spine reflecting on all shoulder area. now it feels on another spine. Its extremlly uncomfortable to be seated or standing, have to lay on an angle. if standing and hurting, I touch spine area and pain from shoulder decreases. Being resting but no improvement.